{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:28:35Z","timestamp":1794378515760,"version":"4.9.0"},"publisher-location":"Berlin, Heidelberg","reference-count":40,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783540705789","type":"print"},{"value":"9783540705796","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009]]},"DOI":"10.1007\/978-3-540-70579-6_13","type":"book-chapter","created":{"date-parts":[[2010,6,30]],"date-time":"2010-06-30T07:46:30Z","timestamp":1277883990000},"page":"155-166","source":"Crossref","is-referenced-by-count":2,"title":["Multimodality Therapy for Adenocarcinoma of the Esophagus, Gastric Cardia, and Upper Gastric Third"],"prefix":"10.1007","author":[{"given":"John V.","family":"Reynolds","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narayamasamy","family":"Ravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,5,18]]},"reference":[{"key":"13_CR1_13","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1056\/NEJMsa012337","volume":"346","author":"JD Birkmeyer","year":"2002","unstructured":"Birkmeyer JD, Siewers AE, Finlayson EV, Stukel TA et al (2002) Hospital volume and surgical mortality in the United States. N Engl J Med 346:1128\u20131137","journal-title":"N Engl J Med"},{"key":"13_CR2_13","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1001\/jama.1991.03460100089030","volume":"265","author":"WJ Blot","year":"1991","unstructured":"Blot WJ, De Vesa SS, Kneller RW, Fraumeni JF Jr (1991) Rising incidence of adenocarcinoma of the oesophagus and gastric cardia. JAMA 265: 1287\u20131289","journal-title":"JAMA"},{"key":"13_CR3_13","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1056\/NEJM199707173370304","volume":"337","author":"J-F Bosset","year":"1997","unstructured":"Bosset J-F, Gignoux M, Tiboulet J-P et al (1997) Chemoradiotherapy followed by surgery compared with surgery alone in squamous cell cancer of the esophagus. N Engl J Med 337:161\u2013167","journal-title":"N Engl J Med"},{"key":"13_CR4_13","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S1470-2045(05)70288-6","volume":"6","author":"BH Burmeister","year":"2005","unstructured":"Burmeister BH, Smithers BM, Gebski V, Fitzgerald L et al (2005) Surgery alone versus chemoradiotherapy followed by surgery for respectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol 6:659\u2013668","journal-title":"Lancet Oncol"},{"key":"13_CR5_13","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1056\/NEJMoa033025","volume":"351","author":"D Cunningham","year":"2004","unstructured":"Cunningham D, Humblet Y, Siena S, Khayat D, Bleiberg H, Santoro A, Bets D, Muese M, Harstrick A, Verslype C, Chau I, Van Cutsem E (2004) Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 351:337\u2013345","journal-title":"N Engl J Med"},{"key":"13_CR6_13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa055531","volume":"355","author":"D Cunningham","year":"2006","unstructured":"Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, Smith DB, Langley RE, Verma M, Weeden S, Chua YJ, MAGIC Trial Participants (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11\u201320","journal-title":"N Engl J Med"},{"key":"13_CR7_13","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1056\/NEJMoa073149","volume":"358","author":"D Cunningham","year":"2008","unstructured":"Cunningham D, Starling N, Rao S, Iveson T et al (2008) Capecitabine and oxaliplatin for advanced esophagogastric cancer. N Engl J Med 358: 36\u201346","journal-title":"N Engl J Med"},{"key":"13_CR8_13","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/S1072-7515(00)00238-6","volume":"190","author":"JM Daly","year":"2000","unstructured":"Daly JM (2000) Esophageal cancer: results of an American College of Surgeons Patient Care Evaluation Study. J Am Coll Surg 190:562\u2013572","journal-title":"J Am Coll Surg"},{"key":"13_CR9_13","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1056\/NEJMra035010","volume":"349","author":"PC Enzinger","year":"2003","unstructured":"Enzinger PC, Mayer RJ (2003) Esophageal Cancer. N Engl J Med 349:2241\u20132252","journal-title":"N Engl J Med"},{"key":"13_CR10_13","doi-asserted-by":"publisher","first-page":"5869","DOI":"10.1158\/1078-0432.CCR-06-1970","volume":"13","author":"DR Ferry","year":"2007","unstructured":"Ferry DR, Anderson M, Beddard K, Tomlinson S, Atherfold P, Obszynska J, Harrison R, Jankowski J (2007) A phase II study of gefitinib monotherapy in advanced esophageal adenocarcinoma: evidence of gene expression, cellular, and clinical response. Clin Cancer Res 13: 5869\u20135875","journal-title":"Clin Cancer Res"},{"key":"13_CR11_13","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1136\/gut.2003.025080","volume":"53","author":"F Fiorica","year":"2004","unstructured":"Fiorica F, DiBona D, Schepis F, Licata A, Shahied L et al (2004) Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis. Gut 53:925\u2013930","journal-title":"Gut"},{"key":"13_CR12_13","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S1470-2045(07)70039-6","volume":"8","author":"V Gebski","year":"2007","unstructured":"Gebski V, Burmeister B, Smithers BM, Foo K, Zalcberg J, Simes J; Australasian Gastro-Intestinal Trials Group (2007) Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 8:226\u2013234","journal-title":"Lancet Oncol"},{"key":"13_CR13_13","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1046\/j.1365-2168.2001.01670.x","volume":"88","author":"JI Geh","year":"2001","unstructured":"Geh JI, Crellin AM, Glynne-Jones R (2001) Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer. Br J Surg 88:338\u2013356","journal-title":"Br J Surg"},{"key":"13_CR40_13","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1038\/sj.bjc.6603412","volume":"95","author":"CM Gillham","year":"2006","unstructured":"Gillham CM, Lucey JA, Keogan M, Duffy GJ, et al (2006) (18) FDG uptake during induction chemoradiation for oesophageal cancer fails to predict histomorphological tumour response. Br J Cancer 95: 1174\u20131179","journal-title":"Br J Cancer"},{"key":"13_CR14_13","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/01.sla.0000141194.27992.32","volume":"240","author":"A Habr-Gama","year":"2004","unstructured":"Habr-Gama A, Perez RO, Nadalin W, Sabbago J et al (2004) Operative versus nonoperative treatment for Stage 0 distal rectal cancer following chemoradiation therapy. Long term results. Ann Surg 240:711\u2013718","journal-title":"Ann Surg"},{"key":"13_CR15_13","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1056\/NEJM199812313392704","volume":"339","author":"DP Kelsen","year":"1998","unstructured":"Kelsen DP, Ginsberg R, Pajak TF et al (1998) Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339:1974\u20131984","journal-title":"N Engl J Med"},{"issue":"2","key":"13_CR16_13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/jso.20070","volume":"87","author":"A Kleespies","year":"2004","unstructured":"Kleespies A, Guba M, Jauch KW, Bruns CJ (2004) Vascular endothelial growth factor in esophageal cancer. Surg Oncol 87(2):95\u2013104","journal-title":"Surg Oncol"},{"key":"13_CR17_13","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/S0360-3016(03)01373-7","volume":"57","author":"HK Lee","year":"2003","unstructured":"Lee HK, Vapociyan AA, Cox JD, Tucker SL et al (2003) Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram parameters. Int J Radiat Oncol Biol Phys 57:1317\u20131322","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"13_CR18_13","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S1470-2045(07)70244-9","volume":"8","author":"F Lordick","year":"2007","unstructured":"Lordick F, Ott K, Krause BJ, Weber WA, Becker K, Stein HJ, Lorenzen S, Schuster T, Wieder H, Herrmann K, Bredenkamp R, H\u00f6fler H, Fink U, Peschel C, Schwaiger M, Siewert JR (2007) PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial. Lancet Oncol 8(9):797\u2013805","journal-title":"Lancet Oncol"},{"key":"13_CR19_13","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1056\/NEJMoa010187","volume":"345","author":"JS Macdonald","year":"2001","unstructured":"Macdonald JS, Smalley SR, Benedetti J, Hundahl SA et al (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of stomach or gastroesophageal junction. N Engl J Med 345:725\u2013730","journal-title":"N Engl J Med"},{"key":"13_CR20_13","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S1470-2045(07)70172-9","volume":"8","author":"C Mariette","year":"2007","unstructured":"Mariette C, Piessen G, Triboulet JP (2007) Therapeutic strategies in oesophageal carcinoma: role of \u00adsurgery and other modalities. Lancet Oncol 8:545\u2013553","journal-title":"Lancet Oncol"},{"key":"13_CR21_13","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1016\/S0140-6736(02)08651-8","volume":"359","author":"Medical Research Council Oesophageal Cancer Working Group","year":"2002","unstructured":"Medical Research Council Oesophageal Cancer Working Group (2002) Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 359:1727\u20131733","journal-title":"Lancet"},{"issue":"24","key":"13_CR22_13","doi-asserted-by":"publisher","first-page":"4692","DOI":"10.1200\/JCO.2006.06.7801","volume":"10","author":"K Ott","year":"2006","unstructured":"Ott K, Weber WA, Lordick F, Becker K, Busch R, Herrmann K, Wieder H, Fink U, Schwaiger M, Siewert JR (2006) Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction. J Clin Oncol 10(24):4692\u20134698","journal-title":"J Clin Oncol"},{"key":"13_CR23_13","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1111\/j.1365-2036.2007.03325.x","volume":"25","author":"CJ Peters","year":"2007","unstructured":"Peters CJ, Fitzgerald RC (2007) Systematic review: the application of molecular pathogenesis to prevention and treatment of oesophageal adenocarcinoma. Aliment Pharmacol Ther 25:1253\u20131269","journal-title":"Aliment Pharmacol Ther"},{"key":"13_CR24_13","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.jamcollsurg.2005.12.022","volume":"202","author":"G Portale","year":"2006","unstructured":"Portale G, Hagen JA, Peters JH, Chan LS et al (2006) Modern 5-year survival of respectable esophageal adenocarcinoma: single institution experience with 263 patients. J Am Coll Surg 202: 588\u2013596","journal-title":"J Am Coll Surg"},{"issue":"20","key":"13_CR25_13","first-page":"4593","volume":"57","author":"LG Presta","year":"1997","unstructured":"Presta LG, Chen H, O\u2019Connor SJ, Chisholm V, Meng YG, Krummen L, Winkler M, Ferrara N (1997) Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. Cancer Res 57(20):4593\u20134599","journal-title":"Cancer Res"},{"key":"13_CR26_13","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jtcvs.2006.05.015","volume":"132","author":"JV Reynolds","year":"2006","unstructured":"Reynolds JV, Ravi N, Hollywood D, Kennedy MJ, Rowley SM, Ryan A, Hughes N, Carey M, Byrne P (2006) Neoadjuvant chemoradiation may increase the risk of respiratory complications and sepsis after transthoracic esophagectomy. J Thorac Cardiovasc Surg 132:549\u2013555","journal-title":"J Thorac Cardiovasc Surg"},{"key":"13_CR27_13","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1097\/01.sla.0000254367.15810.38","volume":"245","author":"JV Reynolds","year":"2007","unstructured":"Reynolds JV, Muldoon C, Hollywood D, Ravi N, Rowley S, O\u2019Byrne K, Kennedy MJ, Murphy TJ (2007) Long-term outcomes following neoadjuvant chemoradiotherapy for oesophageal cancer. Ann Surg 245:707\u2013716","journal-title":"Ann Surg"},{"key":"13_CR28_13","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ijrobp.2007.07.2325","volume":"70","author":"H Safran","year":"2008","unstructured":"Safran H, Suntharalingam M, Dipetrillo T, Ng T, Doyle LA, Krasna M, Plette A, Evans D, Wanebo H, Akerman P, Spector J, Kennedy N, Kennedy T (2008) Cetuximab with concurrent chemoradiation for esophagogastric cancer: assessment of toxicity. Int J Radiat Oncol Biol Phys 70:391\u2013395","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"13_CR29_13","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1056\/NEJMoa040694","volume":"351","author":"R Sauer","year":"2004","unstructured":"Sauer R, Becker H, Hohenberger W et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351: 1731\u20131740","journal-title":"N Engl J Med"},{"key":"13_CR30_13","doi-asserted-by":"publisher","first-page":"5201","DOI":"10.1200\/JCO.2006.08.0887","volume":"24","author":"MA Shah","year":"2006","unstructured":"Shah MA, Ramanathan RK, Ilson DH, Levnor A, D\u2019Adamo D, O\u2019Reilly E, Tse A, Trocola R, Schwartz L, Capanu M, Schwartz GK, Kelsen DP (2006) Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinoma. J Clin Oncol 24:5201\u20135206","journal-title":"J Clin Oncol"},{"key":"13_CR31_13","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1046\/j.1365-2168.1998.00940.x","volume":"85","author":"JR Siewert","year":"1998","unstructured":"Siewert JR, Stein HJ (1998) Classification of adenocarcinoma of the oesophago-gastric junction. Br J Surg 85:1457\u20131459","journal-title":"Br J Surg"},{"key":"13_CR32_13","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/00000658-200009000-00007","volume":"232","author":"JR Siewert","year":"2000","unstructured":"Siewert JR, Feith M, Werner M, Stein HJ (2000) Adenocarcinoma of the esophagastric junction: results of surgical therapy based on anatomical\/topographical classification in 1002 consecutive patients. Ann Surg 232:353\u2013361","journal-title":"Ann Surg"},{"key":"13_CR33_13","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1002\/(SICI)1097-0142(19990615)85:12<2499::AID-CNCR2>3.0.CO;2-T","volume":"85","author":"M Suntharalingam","year":"1999","unstructured":"Suntharalingam M, Mougham J, Coia LR et al (1999) The national practice for patients receiving radiation therapy for carcinoma of the esophagus: results of the 1996-1999 Patterns of Care Study. Cancer 85:2499\u20132505","journal-title":"Cancer"},{"key":"13_CR34_13","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1200\/JCO.2007.12.9593","volume":"26","author":"J Tepper","year":"2008","unstructured":"Tepper J, Krasna MJ, Niedzwiecki D, Hollis D, Reed CE, Goldberg R, Kiel K, Willett C, Sugarbaker D, Mayer R (2008) Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol 26:1086\u20131092","journal-title":"J Clin Oncol"},{"key":"13_CR35_13","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1200\/JCO.2001.19.2.305","volume":"19","author":"SG Urba","year":"2001","unstructured":"Urba SG, Orriner MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M (2001) Randomised trial of preoperative chemoradiotherapy versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19:305\u2013313","journal-title":"J Clin Oncol"},{"key":"13_CR36_13","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1245\/s10434-007-9582-6","volume":"15","author":"L Schoot van de","year":"2008","unstructured":"van de Schoot L, Romme EA, van der Sangen MJ, Creemers GJ, van Lijnschoten G, van Driel OJ, Rutten HJ, Nieuwenhuijzen GA (2008) A highly active and tolerable neoadjuvant regimen combining paclitaxel, carboplatin, 5-FU, and radiation therapy in patients with stage II and III esophageal cancer. Ann Surg Oncol 15:88\u201395","journal-title":"Ann Surg Oncol"},{"key":"13_CR37_13","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1056\/NEJM199608153350702","volume":"335","author":"T Walsh","year":"1996","unstructured":"Walsh T, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TPJ (1996) A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335:462\u2013467","journal-title":"N Engl J Med"},{"issue":"8","key":"13_CR38_13","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/sj.bjc.6600252","volume":"86","author":"J Wayman","year":"2002","unstructured":"Wayman J, Bennett MK, Raimes SA, Griffin SM (2002) The pattern of recurrence of adenocarcinoma of the oesophago-gastric junction. Br J Cancer 86(8):1223\u20131229","journal-title":"Br J Cancer"},{"key":"13_CR39_13","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1200\/JCO.2001.19.12.3058","volume":"19","author":"WA Weber","year":"2001","unstructured":"Weber WA, Ott K, Becker K, Dittler HJ et al (2001) Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J Clin Oncol 19:3058\u20133065","journal-title":"J Clin Oncol"}],"container-title":["Recent Results in Cancer Research","Adenocarcinoma of the Esophagogastric Junction"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-540-70579-6_13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,30]],"date-time":"2021-10-30T07:10:55Z","timestamp":1635577855000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-540-70579-6_13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"ISBN":["9783540705789","9783540705796"],"references-count":40,"URL":"https:\/\/doi.org\/10.1007\/978-3-540-70579-6_13","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-3-540-70579-6","asserted-by":"object"}]},"ISSN":["0080-0015"],"issn-type":[{"value":"0080-0015","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]}}}